SCHM vs. BOUT
SCHM (Schwab US Mid-Cap ETF) and BOUT (Innovator IBD Breakout Opportunities ETF) are both Mid Cap Growth Equities funds - SCHM tracks the Dow Jones US Total Stock Market Mid-Cap while BOUT tracks the IBD Breakout Stocks Total Return Index. Both are passively managed. Over the past 5 years, SCHM returned 8.07%/yr vs 8.25%/yr for BOUT. A 0.75 correlation means they provide meaningful diversification when combined. SCHM charges 0.04%/yr vs 0.80%/yr for BOUT.
Performance
SCHM vs. BOUT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SCHM achieves a 19.05% return, which is significantly lower than BOUT's 31.39% return.
SCHM
- 1D
- -0.03%
- 1M
- 5.28%
- YTD
- 19.05%
- 6M
- 19.54%
- 1Y
- 32.45%
- 3Y*
- 18.14%
- 5Y*
- 8.07%
- 10Y*
- 11.37%
BOUT
- 1D
- -0.01%
- 1M
- 5.85%
- YTD
- 31.39%
- 6M
- 30.30%
- 1Y
- 35.27%
- 3Y*
- 17.42%
- 5Y*
- 8.25%
- 10Y*
- —
SCHM vs. BOUT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
SCHM Schwab US Mid-Cap ETF | 19.05% | 10.17% | 11.98% | 16.69% | -17.07% | 19.36% | 15.26% | 27.48% | -17.52% |
BOUT Innovator IBD Breakout Opportunities ETF | 31.39% | -6.77% | 18.82% | 13.27% | -22.60% | 22.69% | 50.56% | 20.59% | -29.80% |
Correlation
The correlation between SCHM and BOUT is 0.76, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.76 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.80 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.79 |
Correlation (All Time) Calculated using the full available price history since Sep 14, 2018 | 0.75 |
The correlation between SCHM and BOUT has been stable across timeframes, ranging from 0.75 to 0.80 - a consistent structural relationship.
SCHM vs. BOUT - Sectors Allocation Comparison
Sectors
SCHM
BOUT
Technology
Industrials
Financial Services
Healthcare
Consumer Cyclical
Real Estate
Basic Materials
Consumer Defensive
Energy
Utilities
Communication Services
Technology
SCHM
BOUT
Industrials
SCHM
BOUT
Financial Services
SCHM
BOUT
Healthcare
SCHM
BOUT
Consumer Cyclical
SCHM
BOUT
Real Estate
SCHM
BOUT
Basic Materials
SCHM
BOUT
Consumer Defensive
SCHM
BOUT
Energy
SCHM
BOUT
Utilities
SCHM
BOUT
Communication Services
SCHM
BOUT
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SCHM vs. BOUT — Risk / Return Rank
SCHM
BOUT
SCHM vs. BOUT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Schwab US Mid-Cap ETF (SCHM) and Innovator IBD Breakout Opportunities ETF (BOUT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SCHM | BOUT | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.09 | 1.71 | +0.39 |
Sortino ratioReturn per unit of downside risk | 2.94 | 2.33 | +0.61 |
Omega ratioGain probability vs. loss probability | 1.36 | 1.30 | +0.07 |
Calmar ratioReturn relative to maximum drawdown | 3.50 | 3.01 | +0.49 |
Martin ratioReturn relative to average drawdown | 14.11 | 9.00 | +5.11 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SCHM | BOUT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.09 | 1.71 | +0.39 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.41 | 0.43 | -0.01 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.56 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.59 | 0.41 | +0.18 |
Drawdowns
SCHM vs. BOUT - Drawdown Comparison
The maximum SCHM drawdown since its inception was -42.43%, which is greater than BOUT's maximum drawdown of -36.75%. Use the drawdown chart below to compare losses from any high point for SCHM and BOUT.
Loading charts...
Drawdown Indicators
| SCHM | BOUT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.43% | -36.75% | -5.68% |
Max Drawdown (1Y)Largest decline over 1 year | -9.32% | -11.76% | +2.44% |
Max Drawdown (3Y)Largest decline over 3 years | -23.27% | -25.31% | +2.04% |
Max Drawdown (5Y)Largest decline over 5 years | -26.46% | -28.28% | +1.82% |
Max Drawdown (10Y)Largest decline over 10 years | -42.43% | — | — |
Current DrawdownCurrent decline from peak | -0.03% | -0.01% | -0.02% |
Average DrawdownAverage peak-to-trough decline | -5.66% | -12.29% | +6.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.31% | 3.93% | -1.62% |
Volatility
SCHM vs. BOUT - Volatility Comparison
The current volatility for Schwab US Mid-Cap ETF (SCHM) is 4.72%, while Innovator IBD Breakout Opportunities ETF (BOUT) has a volatility of 5.96%. This indicates that SCHM experiences smaller price fluctuations and is considered to be less risky than BOUT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SCHM | BOUT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.72% | 5.96% | -1.24% |
Volatility (6M)Calculated over the trailing 6-month period | 11.74% | 16.05% | -4.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.62% | 20.79% | -5.17% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.56% | 19.48% | +0.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.46% | 22.93% | -2.47% |
SCHM vs. BOUT - Expense Ratio Comparison
SCHM has a 0.04% expense ratio, which is lower than BOUT's 0.80% expense ratio.
Dividends
SCHM vs. BOUT - Dividend Comparison
SCHM's dividend yield for the trailing twelve months is around 1.22%, more than BOUT's 0.26% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BOUT Innovator IBD Breakout Opportunities ETF | 0.26% | 0.34% | 0.60% | 1.32% | 1.35% | 0.00% | 0.00% | 0.00% | 0.22% | 0.00% | 0.00% | 0.00% |
SCHM Schwab US Mid-Cap ETF | 1.22% | 1.46% | 1.43% | 1.50% | 1.67% | 1.13% | 1.31% | 1.48% | 1.56% | 1.27% | 1.51% | 1.54% |
Frequently Asked Questions
SCHM and BOUT have a correlation of 0.76, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BOUT has higher volatility (5.96%) compared to SCHM (4.72%). In terms of maximum drawdown, SCHM dropped -42.43% vs BOUT's -36.75%.
On 5-year performance, BOUT leads with 8.25% vs 8.07% for SCHM. On fees, SCHM is cheaper at 0.04% per year. On volatility, SCHM has been the lower-risk option at 4.72%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, BOUT has performed better with a 8.25% return vs 8.07%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SCHM is cheaper with a 0.04% expense ratio, compared with 0.80% for BOUT.
SCHM has the higher dividend yield at 1.22%, compared with 0.26% for BOUT.
SCHM tracks Dow Jones US Total Stock Market Mid-Cap, while BOUT tracks IBD Breakout Stocks Total Return Index. They also come from different issuers: Charles Schwab and Innovator. Their fees differ too: 0.04% for SCHM and 0.80% for BOUT.
SCHM currently has the higher Sharpe Ratio (2.09 vs 1.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SCHM and BOUT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer